Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors.
Ontology highlight
ABSTRACT: Cancer immunotherapies strive to overcome tumor-induced immune suppression and activate antitumor immune responses. Although cytotoxic T lymphocytes (CTLs) play a pivotal role in this process, natural killer (NK) cells have also demonstrated remarkable tumor-killing abilities, given their ability to discriminate tumor cells from normal cells and mediate specific antitumoral cytotoxicity. NK cells activation depends on a balance between activation and inhibition signals from several ligands/receptors. Among them, MICA/NKG2D axis is a master regulator of NK activation. MHC class I chain-related polypeptide A (MICA) expression is upregulated by many tumor cell lines and primary tumors and serves as a ligand for the activating NK group 2D (NKG2D) receptor on NK cells and subpopulations of T ce
SUBMITTER: Costa-Garcia M
PROVIDER: S-EPMC10770194 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA